×
Entrez Id:
207
Gene Symbol:
AKT1
AKT1
0.310
GeneticVariation
disease
BEFREE
Durable Control of Metastatic AKT1 -Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
28376212
2017
×
Entrez Id:
207
Gene Symbol:
AKT1
AKT1
0.310
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
8314
Gene Symbol:
BAP1
BAP1
0.300
Biomarker
disease
CTD_human
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
25231345
2015
×
Entrez Id:
6608
Gene Symbol:
SMO
SMO
0.300
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
4771
Gene Symbol:
NF2
NF2
0.300
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
8028
Gene Symbol:
MLLT10
MLLT10
0.300
Biomarker
disease
CTD_human
Common variation at 10p12.31 near MLLT10 influences meningioma risk.
21804547
2011
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
3280
Gene Symbol:
HES1
HES1
0.300
Biomarker
disease
CTD_human
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
21127729
2010
×
Entrez Id:
1514
Gene Symbol:
CTSL
CTSL
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
1476
Gene Symbol:
CSTB
CSTB
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.300
Biomarker
disease
CTD_human
Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.
19731987
2010
×
Entrez Id:
1471
Gene Symbol:
CST3
CST3
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
210
Gene Symbol:
ALAD
ALAD
0.300
Biomarker
disease
CTD_human
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.
16140629
2005
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
0.300
Biomarker
disease
CTD_human
A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
12085208
2002
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.300
Biomarker
disease
CTD_human
Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
8008172
1994
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.010
AlteredExpression
disease
BEFREE
Epidermal growth factor receptor overexpressed malignant fibrous histiocytoma associated with recurrent meningothelial meningioma .
19940402
2009
×
Entrez Id:
6750
Gene Symbol:
SST
SST
0.010
AlteredExpression
disease
BEFREE
Furthermore, the high expression of sst2 in meningothelial meningioma suggests the possibility of a different tumorigenesis process in this meningioma subtype and may open perspectives for the diagnosis and therapy of this subtype using somatostatin as an antiproliferative agent.
18808065
2008
×
Entrez Id:
7015
Gene Symbol:
TERT
TERT
0.010
GeneticVariation
disease
BEFREE
We have developed a meningioma cell line by retrovirally transducing primary cells derived from a human WHO grade I meningothelial meningioma with the human telomerase reverse transcriptase (hTERT ) gene, which enables bypassing cellular senescence.
15965488
2005